NL-OMON54493招募中不适用
Early diagnostic BioMARKers in Exacerbations of COPD: the MARKED study - the MARKED study
Ciro0 个研究点目标入组 162 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 162
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •COPD patients:
- •In order to be eligible to participate in this study, a patient must meet all
- •of the following criteria:
- •- >= 40 years old
- •- >= 10 packyears of smoking
- •- primary diagnosis of COPD and post-bronchodilator ratio of forced expiratory
- •volume in the first second (FEV1) to forced vital capacity (FVC) of less than
- •- clinical indication for inpatient pulmonary rehabilitation in CIRO
- •- provided written informed consent
排除标准
- •A potential COPD patient who meets any of the following criteria will be
- •excluded from participation in this study:
- •- current diagnosis of asthma
- •- unstable concurrent cardiovascular, metabolic, renal, gastro-intestinal and
- •musculoskeletal chronic diseases (as judged by the investigator)
- •- chronic use of oral corticosteroids >10 mg prednisolone/day
- •- initiation of maintenance therapy with macrolides < 6 weeks prior to study
- •- anemia, defined as hemoglobin level < 8.1 mmol/L in men and < 7.5 mmol/L in
- •- participation in a study involving investigational or marketed products
- •concomitantly or < 8 weeks prior to study entry
- •- unable to read, speak or understand Dutch
研究者
相似试验
尚未招募
不适用
Practical biomarkers for the early detection of dementiamemory problems10012272DementiaNL-OMON40141niversity College Roosevelt210
已完成
不适用
Prehospital Evaluation and Detection of Induced Coagulopathy in TraumaTRAUMAINDIZIERTEKOAGULOPATHIED65Disseminated intravascular coagulation [defibrination syndrome]DRKS00009559Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin148
已完成
不适用
Identification of biomarkers that correlate with clinical features and outcomes following concussioACTRN12615000543583The University of Western Australia80
尚未招募
不适用
Serosurvey for antibodies against SARS-CoV-2 in Pune cityCTRI/2020/07/026509Persisten Foundation
尚未招募
不适用
Identification of exacerbation markers in chronic inflammatory airway diseasesAsthmaJ45J44Other chronic obstructive pulmonary diseaseDRKS00000632Forschungszentrum BorstelLaborgruppe Mukosaimmunologie120
